Antineoplastic drug NSC631570 modulates functions of hypoxic macrophages.
Hypoxia is an important factor in the macrophages microenvironment. Many physiological and pathological processes including solid tumor development are characterized by both low oxygen content and presence of macrophages. Tumor-associated hypoxia causes alternative polarization of macrophages in tumor tissue and transformation of these cells into the allies of a malignant neoplasm. The aim of the work was to investigate the effect of NSC631570, a cancer-selective drug that is known to selectively accumulate in the tumor tissue, on hypoxic macrophage function. Murine peritoneal macrophages (PMs) were subjected to hypoxia (3% O2). Nitrite level was assayed by the Griess reaction. Arginase activity was measured by colorimetric method. ROS generation and phagocytosis was estimated by flow cytometry. O2(-) generation was assayed by the NBT reduction method. HMGB1 expression was determined by ELISA. 42 h hypoxia caused alternative polarization of murine PMs with significant arginase prevalence. NSC631570 repolarized arginine metabolism of hypoxic macrophages to NOS dominant and activated their pro-inflammatory functions: recovered ROS production and increased alarmin release NSC631570 can restore pro-inflammatory functions of macrophages, alternatively polarized by hypoxia.
Taras Shevchenko National University of Kyiv, Ukraine. realmed@i.com.ua
L M
LM
Skivka
O G
OG
Fedorchuk
M P
MP
Rudyk
V V
VV
Pozur
N M
NM
Khranovska
M Yu
MY
Grom
J W
JW
Nowicky
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology*; D001119:Arginase / Q000235:genetics / Q000378:metabolism; D001600:Berberine Alkaloids / Q000494:pharmacology*; D015687:Cell Hypoxia / Q000187:drug effects / Q000235:genetics; D015870:Gene Expression / Q000187:drug effects; D024243:HMGB1 Protein / Q000235:genetics / Q000378:metabolism; D017737:Macrophages, Peritoneal / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D008297:Male; D051379:Mice; D009569:Nitric Oxide / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II / Q000235:genetics / Q000378:metabolism; D009573:Nitrites / Q000378:metabolism; D010587:Phagocytosis / Q000187:drug effects* / Q000502:physiology; D010617:Phenanthridines / Q000494:pharmacology*; D061251:Primary Cell Culture; D013481:Superoxides / Q000378:metabolism
D000470:Alkaloids; D000972:Antineoplastic Agents, Phytogenic; D001600:Berberine Alkaloids; D024243:HMGB1 Protein; C582808:HMGB1 protein, mouse; D009573:Nitrites; D010617:Phenanthridines; D013481:Superoxides; D009569:Nitric Oxide; C060921:ukrain; D052247:Nitric Oxide Synthase Type II; D001119:Arginase